Rafael Holdings Inc is a biotechnology business based in the US. Rafael shares (RFL) are listed on the NYSE and all prices are listed in US Dollars. Rafael employs 51 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Active traders
Our top pick for
Beginners
Our top pick for
Building a portfolio
| Latest market close | $4.97 |
|---|---|
| 52-week range | $4.50 - $66.44 |
| 50-day moving average | $5.99 |
| 200-day moving average | $34.11 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-8.69 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.97 from 2022-01-14
| 1 week (2022-01-07) | 5.74% |
|---|---|
| 1 month (2021-12-17) | -6.23% |
| 3 months (2021-10-15) | -83.73% |
| 6 months (2021-07-16) | -91.02% |
| 1 year (2021-01-15) | -80.32% |
|---|---|
| 2 years (2020-01-16) | -75.49% |
| 3 years (2019-01-16) | 12.705 |
| 5 years (2017-01-13) | N/A |
| Revenue TTM | $3.9 million |
|---|---|
| Gross profit TTM | $4 million |
| Return on assets TTM | -16.38% |
| Return on equity TTM | -126.04% |
| Profit margin | 0% |
| Book value | $4.78 |
| Market capitalisation | $97.3 million |
TTM: trailing 12 months
We're not expecting Rafael to pay a dividend over the next 12 months.
Over the last 12 months, Rafael's shares have ranged in value from as little as $4.5 up to $66.44. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Rafael's is 1.9272. This would suggest that Rafael's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Donut earns up to 10% APY, but you must have an iOS device.
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
Everything we know about the VinFast IPO, plus information on how to buy in.
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.